|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMSP0505AE04
|
type II B antigen(d18:1/22:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc-Fuc-Cer 40:1;O2
|
C78H142N2O32
|
1618.954578
|
|
LMSP0505AE05
|
type II B antigen(d18:1/24:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc-Fuc-Cer 42:1;O2
|
C80H146N2O32
|
1646.985878
|
|
LMSP0505AE06
|
type II B antigen(d18:1/26:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc-Fuc-Cer 44:1;O2
|
C82H150N2O32
|
1675.017178
|
|
LMSP0505AE07
|
type II B antigen(d18:1/24:1(15Z))
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc-Fuc-Cer 42:2;O2
|
C80H144N2O32
|
1644.970228
|
|
LMSP0505AE08
|
type II B antigen(d18:1/26:1(17Z))
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc-Fuc-Cer 44:2;O2
|
C82H148N2O32
|
1673.001528
|
|
LMSP0505AF01
|
type II A antigen(d18:1/16:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 34:1;O2
|
C74H133N3O32
|
1575.887227
|
|
LMSP0505AF02
|
type II A antigen(d18:1/18:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 36:1;O2
|
C76H137N3O32
|
1603.918527
|
|
LMSP0505AF03
|
type II A antigen(d18:1/20:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 38:1;O2
|
C78H141N3O32
|
1631.949827
|
|
LMSP0505AF04
|
type II A antigen(d18:1/22:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C80H145N3O32
|
1659.981127
|
|
LMSP0505AF05
|
type II A antigen(d18:1/24:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 42:1;O2
|
C82H149N3O32
|
1688.012427
|
|
LMSP0505AF06
|
type II A antigen(d18:1/26:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 44:1;O2
|
C84H153N3O32
|
1716.043727
|
|
LMSP0505AF07
|
type II A antigen(d18:1/24:1(15Z))
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(3)-HexNAc(2)-Fuc-Cer 42:2;O2
|
C82H147N3O32
|
1685.996777
|
|
LMSP0505AF08
|
type II A antigen(d18:1/26:1(17Z))
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(3)-HexNAc(2)-Fuc-Cer 44:2;O2
|
C84H151N3O32
|
1714.028077
|
|
LMSP0505AG01
|
Ley-6(d18:1/16:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 34:1;O2
|
C72H130N2O31
|
1518.865763
|
|
LMSP0505AG02
|
Ley-6(d18:1/18:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 36:1;O2
|
C74H134N2O31
|
1546.897063
|
|
LMSP0505AG03
|
Ley-6(d18:1/20:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 38:1;O2
|
C76H138N2O31
|
1574.928363
|
|
LMSP0505AG04
|
Ley-6(d18:1/22:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 40:1;O2
|
C78H142N2O31
|
1602.959663
|
|
LMSP0505AG05
|
Ley-6(d18:1/24:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 42:1;O2
|
C80H146N2O31
|
1630.990963
|
|
LMSP0505AG06
|
Ley-6(d18:1/26:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 44:1;O2
|
C82H150N2O31
|
1659.022263
|
|
LMSP0505AG07
|
Ley-6(d18:1/24:1(15Z))
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(3)-HexNAc-Fuc(2)-Cer 42:2;O2
|
C80H144N2O31
|
1628.975313
|
|
LMSP0505AG08
|
Ley-6(d18:1/26:1(17Z))
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(3)-HexNAc-Fuc(2)-Cer 44:2;O2
|
C82H148N2O31
|
1657.006613
|
|
LMSP0505AH01
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 34:1;O2
|
C80H143N3O37
|
1737.940052
|
|
LMSP0505AH02
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 36:1;O2
|
C82H147N3O37
|
1765.971352
|
|
LMSP0505AH03
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 38:1;O2
|
C84H151N3O37
|
1794.002652
|
|
LMSP0505AH04
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C86H155N3O37
|
1822.033952
|
|
LMSP0505AH05
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 42:1;O2
|
C88H159N3O37
|
1850.065252
|
|
LMSP0505AH06
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 44:1;O2
|
C90H163N3O37
|
1878.096552
|
|
LMSP0505AH07
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(2)-Fuc-Cer 42:2;O2
|
C88H157N3O37
|
1848.049602
|
|
LMSP0505AH08
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(2)-Fuc-Cer 44:2;O2
|
C90H161N3O37
|
1876.080902
|
|
LMSP0505AI01
|
type III H antigen(d18:1/16:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 34:1;O2
|
C86H153N3O41
|
1883.997962
|
|
LMSP0505AI02
|
type III H antigen(d18:1/18:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 36:1;O2
|
C88H157N3O41
|
1912.029262
|
|
LMSP0505AI03
|
type III H antigen(d18:1/20:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 38:1;O2
|
C90H161N3O41
|
1940.060562
|
|
LMSP0505AI04
|
type III H antigen(d18:1/22:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 40:1;O2
|
C92H165N3O41
|
1968.091862
|
|
LMSP0505AI05
|
type III H antigen(d18:1/24:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 42:1;O2
|
C94H169N3O41
|
1996.123162
|
|
LMSP0505AI06
|
type III H antigen(d18:1/26:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 44:1;O2
|
C96H173N3O41
|
2024.154462
|
|
LMSP0505AI07
|
type III H antigen(d18:1/24:1(15Z))
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 42:2;O2
|
C94H167N3O41
|
1994.107512
|
|
LMSP0505AI08
|
type III H antigen(d18:1/26:1(17Z))
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 44:2;O2
|
C96H171N3O41
|
2022.138812
|
|
LMSP0505AJ01
|
type III A antigen(d18:1/16:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 34:1;O2
|
C94H166N4O46
|
2087.077336
|
|
LMSP0505AJ02
|
type III A antigen(d18:1/18:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 36:1;O2
|
C96H170N4O46
|
2115.108636
|
|
LMSP0505AJ03
|
type III A antigen(d18:1/20:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 38:1;O2
|
C98H174N4O46
|
2143.139936
|
|
LMSP0505AJ04
|
type III A antigen(d18:1/22:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 40:1;O2
|
C100H178N4O46
|
2171.171236
|
|
LMSP0505AJ05
|
type III A antigen(d18:1/24:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 42:1;O2
|
C102H182N4O46
|
2199.202536
|
|
LMSP0505AJ06
|
type III A antigen(d18:1/26:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 44:1;O2
|
C104H186N4O46
|
2227.233836
|
|
LMSP0505AJ07
|
type III A antigen(d18:1/24:1(15Z))
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 42:2;O2
|
C102H180N4O46
|
2197.186886
|
|
LMSP0505AJ08
|
type III A antigen(d18:1/26:1(17Z))
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 44:2;O2
|
C104H184N4O46
|
2225.218186
|
|
LMSP0505AK01
|
nLc5Cer(d18:1/16:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(3)-HexNAc(2)-Cer 34:1;O2
|
C68H123N3O28
|
1429.829317
|
|
LMSP0505AK02
|
nLc5Cer(d18:1/18:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc(2)-Cer 36:1;O2
|
C70H127N3O28
|
1457.860617
|
|
LMSP0505AK03
|
nLc5Cer(d18:1/20:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc(2)-Cer 38:1;O2
|
C72H131N3O28
|
1485.891917
|
|
LMSP0505AK04
|
nLc5Cer(d18:1/22:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc(2)-Cer 40:1;O2
|
C74H135N3O28
|
1513.923217
|
|
LMSP0505AK05
|
nLc5Cer(d18:1/24:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(3)-HexNAc(2)-Cer 42:1;O2
|
C76H139N3O28
|
1541.954517
|